Alzinova AB (FRA:78D) Total Liabilities: €0.92 Mil (As of Mar. 2026)


FRA:78D Alzinova AB FRA:78D
21 GF Score
Price €0.03
! 1 Warning Sign
View Full Analysis

What is Alzinova AB Total Liabilities?

Alzinova AB FRA:78D -2.61% 21 Total Liabilities is €0.92 Mil as of Mar. 2026. GuruFocus rates FRA:78D with a GF Score™ of 21/100. The stock has 1 warning sign investors should review.

Alzinova AB's Total Liabilities for the quarter that ended in Mar. 2026 was €0.92 Mil.

Alzinova AB's quarterly Total Liabilities increased from Sep. 2025 (€0.82 Mil) to Dec. 2025 (€1.97 Mil) but then declined from Dec. 2025 (€1.97 Mil) to Mar. 2026 (€0.92 Mil).

Alzinova AB's annual Total Liabilities declined from Dec. 2023 (€0.83 Mil) to Dec. 2024 (€0.82 Mil) but then increased from Dec. 2024 (€0.82 Mil) to Dec. 2025 (€1.97 Mil).

Alzinova AB Total Liabilities Historical Data

* Premium members only.

The historical data trend for Alzinova AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzinova AB Total Liabilities Chart

Alzinova AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.55 0.83 0.82 1.97

Alzinova AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.88 0.81 0.82 1.97 0.92
FRA:78D
21GF Score
Alzinova AB FRA:78D
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzinova AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Alzinova AB's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.82+(0.074+0.079
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.97

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=13.18-11.207
=1.97

Alzinova AB's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.846+(0+0.074
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.92

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=14.727-13.806
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €0.92 Mil mean?
Alzinova AB (FRA:78D) has a Total Liabilities of €0.92 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Alzinova AB and its competitors.
Is Alzinova AB's Total Liabilities too high?
Alzinova AB's current Total Liabilities is €0.92 Mil. Overall, Alzinova AB has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Alzinova AB's Total Liabilities compare to VRTX and REGN?
Alzinova AB's Total Liabilities of €0.92 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Alzinova AB and its competitors. Alzinova AB's current Total Liabilities is €0.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzinova AB stock overvalued right now?
Alzinova AB (FRA:78D) has a current Total Liabilities of €0.92 Mil. The current Total Liabilities is €0.92 Mil. Alzinova AB's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Alzinova AB (FRA:78D), the current Total Liabilities is €0.92 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alzinova AB Business Description

Other Exchanges ALZ:Sweden78D:Germany
Address Entreprenorsstraket 10, Molndal, SWE, 431 53
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is developing ALZ-101, an oligomer-specific therapeutic vaccine currently advancing toward Phase 2 clinical development, and ALZ-201, a monoclonal antibody targeting toxic amyloid-beta (AB) oligomers, which is in preclinical development. The company's proprietary ABCC peptide technology is focused on disease-modifying treatments for Alzheimer's disease.
21GF Score

Get the complete analysis for FRA:78D

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price